Le Perreux, France

Michel Broquaire

This inventor holds 1 USPTO granted patent. Top assignee: Cephalon France. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Broquaire. Retrieved from https://idiyas.com/inventor/michel-broquaire

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Broquaire: Innovator in Pharmaceutical Chemistry

Introduction

Michel Broquaire is a notable inventor based in Le Perreux, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on modafinil polymorphic forms. His innovative approach has led to advancements in therapeutic treatments involving this compound.

Latest Patents

Michel Broquaire holds a patent for "Modafinil polymorphic forms - Polymorphic forms of modafinil racemate, methods of preparation thereof, pharmaceutical compositions and methods of therapeutic treatment involving modafinil polymorphic forms." This patent highlights his expertise in developing new forms of modafinil, which is widely used for its wakefulness-promoting properties.

Career Highlights

Throughout his career, Michel has been associated with Cephalon France, where he has played a crucial role in research and development. His work has not only contributed to the company's portfolio but has also impacted the pharmaceutical industry at large.

Collaborations

Michel has collaborated with several professionals in his field, including Véronique Broquaire, who serves as a Legal Representative, and Laurent Courvoisier. These collaborations have enhanced the quality and scope of his research.

Conclusion

In summary, Michel Broquaire is a distinguished inventor whose work on modafinil polymorphic forms has made a significant impact in pharmaceutical chemistry. His contributions continue to influence therapeutic treatments and the industry as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…